ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements

Sun, Yongkun; Zhang, Wen; Bi, Xinyu; Yang, Zhengqiang; Tang, Yu; Jiang, Liming; Bi, Feng; Chen, Minshan; Cheng, Shuqun; Chi, Yihebali; Han, Yue; Huang, Jing; Huang, Zhen; Ji, Yuan; Jia, Liqun; Jiang, Zhichao; Jin, Jing; Jin, Zhengyu; Li, Xiao; Li, Zhiyu; Liang, Jun; Liu, Lianxin; Liu, Yunpeng; Lu, Yinying; Lu, Shichun; Meng, Qinghua; Niu, Zuoxing; Pan, Hongming; Qin, Shukui; Qu, Wang; Shao, Guoliang; Shen, Feng; Song, Tianqiang; Song, Yan; Tao, Kaishan; Tian, Aiping; Wang, Jianhua复旦大学; 北京大学; 吉林大学; 青岛大学; 山东省医学科学院; 哈尔滨医科大学; 浙江大学; 中国人民解放军第四军医大学; 中国医科大学; 中国医学科学院; 中山大学; 中国科学院研究生院; 中国医学科学院北京协和医院; 6; 1; 5
Liver Cancer2022-6DOI: 10.1159/000521596
16被引29阅读
引用收藏
分享

摘要

Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and causes many cancer-related deaths worldwide; in China, it is the second most prevalent cause of cancer deaths. Most patients are diagnosed clinically with advanced stage disease. Summary: For more than a decade, sorafenib, a small-molecular-weight tyrosine kinase inhibitor (SMW-TKI) was the only molecular targeted drug available with a survival benefit for the treatment of advanced HCC. With the development of novel TKIs and immune checkpoint inhibitors for advanced HCC, the management of patients has been greatly improved. However, though angiogenic-based targeted therapy remains the backbone for the systemic treatment of HCC, to date, no Chinese guidelines for novel molecular targeted therapies to treat advanced HCC have been established. Our interdisciplinary panel on the treatment of advanced HCC comprising hepatologists, hepatobiliary surgeons, oncologists, radiologists, pathologists, orthopedic surgeons, traditional Chinese medicine physicians, and interventional radiologists has reviewed the literature in order to develop updated treatment regimens. Key Messages: Panel consensus statements for the appropriate use of new molecular -targeted drugs including doses, combination therapies, adverse reaction management as well as efficacy evaluation, and predictions for treatment of advanced HCC with evidence levels based on published data are presented, thereby providing an overview of molecular targeted therapies for healthcare professionals.

学科与关键词

关键词
Chinese interdisciplinary expertsHepatocellular carcinomaMolecular targeted therapyConsensus
相关
加载中…
  • Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
    Yang, Yu; Sun, Juxian; Wu, Mengchao; Lau, Wan Yee; Zheng, Shusen; Wang, Xue-Hao; Chen, Xiaoping; Fan, Jia; Dong, Jiahong; Cai, Jianqiang; Chen, Minshan; Chen, Yongjun; Cheng, Zhangjun; Dai, Chaoliu; Shan, Jianzhen; Du, Cheng-You; Fang, Chihua; Hu, Heping; Ji, Zhili; Jia, Weidong; Li, Gong; Li, Jing; Li, Jiangtao; Liu, Chang; Liu, Fubao; Ma, Yong; Mao, Yilei; Niu, Zuoxing; Shen, Jie; Shi, Jie; Shi, Xuetao; Song, Wenjie; Sun, Hui-Chuan; Tan, Guang; Tao, Ran; Wang, Xiaohu; Wen, Tianfu; Wu, LiqunLiver Cancer, 2022, 11(6): 511-526.被引 9
  • The advanced development of molecular targeted therapy for hepatocellular carcinoma
    Yan, Tao; Yu, Lingxiang; Zhang, Ning; Peng, Caiyun; Su, Guodong; Jing, Yi; Zhang, Linzhi; Wu, Tong; Cheng, Jiamin; Guo, Qian; Shi, Xiaoliang*; Lu, Yinying*Cancer Biology & Medicine, 2022, 19(6): 802-817.被引 17
  • Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
    Zhao, Ming*; Guo, Zhi; Zou, Ying-Hua; Li, Xiao; Yan, Zhi-Ping; Chen, Min-Shan; Fan, Wei-Jun; Li, Hai-Liang; Yang, Ji-Jin; Chen, Xiao-Ming; Xu, Lin-Feng; Zhang, Yue-Wei; Zhu, Kang-Shun; Sun, Jun-Hui; Li, Jia-Ping; Jin, Yong; Yu, Hai-Peng; Duan, Feng; Xiong, Bin; Yin, Guo-Wen; Lin, Hai-Lan; Ma, Yi-Long; Wang, Hua-Ming; Gu, Shan-Zhi; Si, Tong-Guo; Wang, Xiao-Dong; Zhao, Chang; Yu, Wen-Chang; Guo, Jian-Hai; Zhai, Jian; Huang, Yong-Hui; Wang, Wei-Yu; Lin, Hai-Feng; Gu, Yang-KuiHepatology International, 2023.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Liver Cancer
发表日期
2022-06
卷期
第 11 卷, 第 3 期
页码
192-208
DOI
10.1159/000521596
期刊等级
1区
成果收录
SCIE
资助标注
State Key Project on Infection Diseases of China [2017ZX10201021-007-003]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2017-12M-4-002]; Non-profit Central Research Institution Fund of Chinese Academy of Medical Sciences [2019PT310026]; Sanming Project of Medicine in Shenzhen [SZSM202011010]; Capital Health Research and Development of Special [2018-1-4021]

作者

  • S

    Sun, Yongkun (第一作者)

    chinese acad med sci · peking union med coll

  • Z

    Zhang, Wen

    chinese acad med sci · peking union med coll

查看全部 64 位作者收起作者
  • B

    Bi, Xinyu

    chinese acad med sci · peking union med coll

  • Y

    Yang, Zhengqiang

    chinese acad med sci · peking union med coll

  • T

    Tang, Yu

    chinese acad med sci · peking union med coll

  • J

    Jiang, Liming

    chinese acad med sci · peking union med coll

  • B

    Bi, Feng

  • C

    Chen, Minshan

    sun yat sen univ

  • C

    Cheng, Shuqun

    6

  • C

    Chi, Yihebali

    chinese acad med sci · peking union med coll

  • H

    Han, Yue

    chinese acad med sci · peking union med coll

  • H

    Huang, Jing

    chinese acad med sci · peking union med coll

  • H

    Huang, Zhen

    chinese acad med sci · peking union med coll

  • J

    Ji, Yuan

    fudan univ

  • J

    Jia, Liqun

    china japan friendship hosp

  • J

    Jiang, Zhichao

    chinese acad med sci · peking union med coll

  • J

    Jin, Jing

    chinese acad med sci · peking union med coll

  • J

    Jin, Zhengyu

    peking union med coll hosp

  • L

    Li, Xiao

    chinese acad med sci · peking union med coll

  • L

    Li, Zhiyu

    chinese acad med sci · peking union med coll

  • L

    Liang, Jun

    peking univ

  • L

    Liu, Lianxin

    1 · univ sci & technol china

  • L

    Liu, Yunpeng

    1 · china med univ

  • L

    Lu, Yinying

    5 · chinese peoples liberat army gen hosp

  • L

    Lu, Shichun

    1 · chinese peoples liberat army pla gen hosp

  • M

    Meng, Qinghua

    capital med univ

  • N

    Niu, Zuoxing

  • P

    Pan, Hongming

    zhejiang univ

  • Q

    Qin, Shukui

    nanjing bayi hosp

  • Q

    Qu, Wang

    chinese acad med sci · peking union med coll

  • S

    Shao, Guoliang

    univ chinese acad sci

  • S

    Shen, Feng

  • S

    Song, Tianqiang

    tianjin med univ canc inst & hosp

  • S

    Song, Yan

    chinese acad med sci · peking union med coll

  • T

    Tao, Kaishan

    fourth mil med univ

  • T

    Tian, Aiping

    chinese acad med sci · peking union med coll

  • W

    Wang, Jianhua

    fudan univ

  • W

    Wang, Wenling

  • W

    Wang, Zhe

    fourth mil med univ

  • W

    Wu, Liqun

    qingdao univ

  • X

    Xia, Feng

  • X

    Xing, Baocai

  • X

    Xu, Jianming

  • X

    Xue, Huadan

    peking union med coll hosp

  • Y

    Yan, Dong

    chinese acad med sci · peking union med coll

  • Y

    Yang, Lin

    chinese acad med sci · peking union med coll

  • Y

    Ying, Jianming

  • Y

    Yun, Jingping

  • Z

    Zeng, Zhaochong

  • Z

    Zhang, Xuewen

  • Z

    Zhang, Yanqiao

  • Z

    Zhang, Yefan

    chinese acad med sci · peking union med coll

  • Z

    Zhao, Jianjun

    chinese acad med sci · peking union med coll

  • Z

    Zhou, Jianguo

    chinese acad med sci · peking union med coll

  • Z

    Zhu, Xu

  • Z

    Zou, Yinghua

  • D

    Dong, Jiahong

  • F

    Fan, Jia

  • L

    Lau, Wan Yee

  • S

    Sun, Yan

    chinese acad med sci · peking union med coll

  • Y

    Yu, Jinming

  • Z

    Zhao, Hong

    chinese acad med sci · peking union med coll

  • Z

    Zhou, Aiping

    chinese acad med sci · peking union med coll

  • C

    Cai, Jianqiang

    chinese acad med sci · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417